FDA delays priority review of Neurotech’s eye cell therapy implant
Neurotech Pharmaceuticals’ eye cell therapy implant has faced a setback as the US Food and Drug Administration (FDA) has extended…
Neurotech Pharmaceuticals’ eye cell therapy implant has faced a setback as the US Food and Drug Administration (FDA) has extended…
The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to treat dry…
Eye health firm Bausch + Lomb has received marketing approval for its full range of enVista Envy vision intraocular lenses…
Johnson & Johnson (J&J), a provider of eye health solutions, has expanded the availability of its TECNIS Odyssey intraocular lens…
Healthcare technology company Visibly has obtained CE mark approval for its Visibly Digital Acuity Product (VDAP) in the European Union…
Two years following a voluntary recall, Roche has relaunched Susvimo (ranibizumab injection) for use as an ocular implant for the…
Digital health company AEYE Health, in collaboration with handheld retinal imaging devices provider Optomed, will launch an autonomous diabetic retinopathy…
Light field technology company Evolution Optiks has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its…
Sight Sciences revealed additional long-term data supporting its TearCare device for the treatment of dry eye disease, indicating it could…
Eye health company Bausch + Lomb has secured regulatory approval from Health Canada for its enVista Envy full visual range…